WASHINGTON — An obscure South Carolina company may be in line for millions of dollars in U.S. government funding to produce a coronavirus treatment after a former Republican senator with a financial stake in the business lobbied senior U.S. government officials.
Plasma Technologies LLC has received seed money to test a possible COVID-19 fighting blood plasma technology. But as much as $65 million more could be on the way — a windfall for the company that operates out of the founder’s luxury condo in Charleston — according to internal government records and other documents obtained by The Associated Press.
The story of how a tiny business, which exists only on paper, has managed to snare so much top-level attention is emblematic of the Trump administration’s frenetic response to the coronavirus pandemic.
And it’s another in a series of contracts awarded despite concerns over their proposals voiced by government scientists. The